Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile Dysfunction
Status:
COMPLETED
Trial end date:
2025-08-19
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if the drug LIB-01 works to treat erectile dysfunction in male adults. It will also learn about the safety of the drug LIB-01. The main questions it aims to answer are:
* Does the drug LIB-01 improve erectile function in males with erectile dysfunction?
* What medical problems do participants have when taking the drug LIB-01? Researchers will compare the drug LIB-01 to a placebo (a look-alike substance that contains no drug) to see if the drug LIB-01 works to treat erectile dysfunction.
Participants will:
* Take the drug LIB-01 or a placebo every day for 3 days
* Visit the clinic every week for 4 weeks, and at 8 weeks, for checkups and tests